Cite

HARVARD Citation

    Carol, H. et al. (n.d.). Initial testing of the MDM2 inhibitor RG7112 by the pediatric preclinical testing program1. Pediatric blood & cancer. 60 (4), pp. 633-641. [Online]. 
  
Back to record